CA Patent

CA2383306A1 — Novel pharmaceutical compositions

Assigned to Wyeth LLC · Expires 2001-04-12 · 25y expired

What this patent protects

Novel pharmaceutical compositions are provided, in particular oral formulations for once a day administration of a drug/medicament and to novel solid dose units for incorporation therein are provided. The solid dose unit s provide a phased release of drug to target or prolong th…

USPTO Abstract

Novel pharmaceutical compositions are provided, in particular oral formulations for once a day administration of a drug/medicament and to novel solid dose units for incorporation therein are provided. The solid dose unit s provide a phased release of drug to target or prolong the pharmaceutical effect. The compositions are particularly useful for multiphase delivery of proton pump inhibitors such as lansoprazole, pantoprazole, omeprazole, perprazole, etc.

Drugs covered by this patent

Patent Metadata

Patent number
CA2383306A1
Jurisdiction
CA
Classification
—
Expires
2001-04-12
Drug substance claim
No
Drug product claim
No
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.